Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Front Immunol ; 12: 625467, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33708216

RESUMO

Bacterial infections in the central nervous system (CNS) can be life threatening and often impair neurological function. Biofilm infection is a complication following craniotomy, a neurosurgical procedure that involves the removal and replacement of a skull fragment (bone flap) to access the brain for surgical intervention. The incidence of infection following craniotomy ranges from 1% to 3% with approximately half caused by Staphylococcus aureus (S. aureus). These infections present a significant therapeutic challenge due to the antibiotic tolerance of biofilm and unique immune properties of the CNS. Previous studies have revealed a critical role for innate immune responses during S. aureus craniotomy infection. Experiments using knockout mouse models have highlighted the importance of the pattern recognition receptor Toll-like receptor 2 (TLR2) and its adaptor protein MyD88 for preventing S. aureus outgrowth during craniotomy biofilm infection. However, neither molecule affected bacterial burden in a mouse model of S. aureus brain abscess highlighting the distinctions between immune regulation of biofilm vs. planktonic infection in the CNS. Furthermore, the immune responses elicited during S. aureus craniotomy infection are distinct from biofilm infection in the periphery, emphasizing the critical role for niche-specific factors in dictating S. aureus biofilm-leukocyte crosstalk. In this review, we discuss the current knowledge concerning innate immunity to S. aureus craniotomy biofilm infection, compare this to S. aureus biofilm infection in the periphery, and discuss the importance of anatomical location in dictating how biofilm influences inflammatory responses and its impact on bacterial clearance.


Assuntos
Biofilmes , Infecções Bacterianas do Sistema Nervoso Central/microbiologia , Craniotomia/efeitos adversos , Imunidade Inata , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/imunologia , Infecção da Ferida Cirúrgica/microbiologia , Animais , Biofilmes/crescimento & desenvolvimento , Infecções Bacterianas do Sistema Nervoso Central/imunologia , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/terapia , Interações Hospedeiro-Patógeno , Humanos , Fator 88 de Diferenciação Mieloide/metabolismo , Infecções Estafilocócicas/imunologia , Infecções Estafilocócicas/metabolismo , Infecções Estafilocócicas/terapia , Staphylococcus aureus/crescimento & desenvolvimento , Infecção da Ferida Cirúrgica/imunologia , Infecção da Ferida Cirúrgica/metabolismo , Infecção da Ferida Cirúrgica/terapia , Receptor 2 Toll-Like/metabolismo
2.
Toxins (Basel) ; 12(5)2020 05 05.
Artigo em Inglês | MEDLINE | ID: mdl-32380697

RESUMO

Although it rarely induces disease in humans, Listeria monocytogenes (Lm) is important due to the frequency of serious pathological conditions-such as sepsis and meningitis-it causes in those few people that do get infected. Virulence factors (VF) of Lm-especially those involved in the passage through multiple cellular barriers of the body, including internalin (Inl) family members and listeriolysin O (LLO)-have been investigated both in vitro and in vivo, but the majority of work was focused on the mechanisms utilized during penetration of the gut and fetoplacental barriers. The role of listerial VF during entry into other organs remain as only partially solved puzzles. Here, we review the current knowledge on the entry of Lm into one of its more significant destinations, the brain, with a specific focus on the role of various VF in cellular adhesion and invasion.


Assuntos
Encéfalo/microbiologia , Infecções Bacterianas do Sistema Nervoso Central/microbiologia , Listeria monocytogenes/metabolismo , Listeriose/microbiologia , Fatores de Virulência/metabolismo , Animais , Aderência Bacteriana , Proteínas de Bactérias/metabolismo , Toxinas Bacterianas/metabolismo , Encéfalo/metabolismo , Encéfalo/patologia , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/patologia , Proteínas de Choque Térmico/metabolismo , Proteínas Hemolisinas/metabolismo , Interações Hospedeiro-Patógeno , Humanos , Listeria monocytogenes/patogenicidade , Listeriose/metabolismo , Listeriose/patologia , Virulência
3.
Eur Rev Med Pharmacol Sci ; 21(17): 3944-3949, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28975967

RESUMO

OBJECTIVE: To study the application value of procalcitonin (PCT) in patients with central nervous system (CNS) infection. PATIENTS AND METHODS: A total of 66 patients, including 24 patients with suppurative meningitis, 20 patients with viral meningitis and 22 patients with tuberculous meningitis, were enrolled. 20 patients admitted to the hospital due to epilepsy or headache without infection in the same period were enrolled as the control group. PCT, high-sensitivity C-reactive protein (Hs-CRP), high-sensitivity C-reactive protein (Hs-CRP), protein quantification, chloride and glucose in serum and cerebrospinal fluid, were collected. RESULTS: The serum PCT level in suppurative meningitis group was significantly higher than that in other three groups. The dynamic monitoring of suppurative meningitis group on admission, at 72 h and 1 week after treatment showed that the serum PCT level was significantly decreased. PCT levels in cerebrospinal fluid in suppurative meningitis group, viral meningitis group and tuberculous meningitis group were decreased successively, and the differences were statistically significant. The detection of PCT in cerebrospinal fluid was more valuable than serum PCT detection in distinguishing tuberculous meningitis from viral meningitis. Continuous monitoring of changes in PCT in cerebrospinal fluid showed that there was no statistically significant difference before and after treatment. PCT level in cerebrospinal fluid was positively correlated with the serum PCT, cerebrospinal fluid white blood cell (WBC), and protein content in cerebrospinal fluid. CONCLUSIONS: The dynamic changes of serum PCT in patients with suppurative meningitis can be used to evaluate the disease, guide the clinical medication, and monitor the prognosis.


Assuntos
Calcitonina/sangue , Infecções Bacterianas do Sistema Nervoso Central/diagnóstico , Precursores de Proteínas/sangue , Adulto , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Proteína C-Reativa/análise , Calcitonina/líquido cefalorraquidiano , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Feminino , Humanos , Leucócitos/citologia , Masculino , Meningites Bacterianas/diagnóstico , Meningites Bacterianas/metabolismo , Meningite Viral/diagnóstico , Meningite Viral/metabolismo , Pessoa de Meia-Idade , Prognóstico , Precursores de Proteínas/líquido cefalorraquidiano , Tuberculose Meníngea/diagnóstico , Tuberculose Meníngea/metabolismo
4.
PLoS One ; 8(1): e54673, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23355888

RESUMO

The brain is assumed to be a sterile organ in the absence of disease although the impact of immune disruption is uncertain in terms of brain microbial diversity or quantity. To investigate microbial diversity and quantity in the brain, the profile of infectious agents was examined in pathologically normal and abnormal brains from persons with HIV/AIDS [HIV] (n = 12), other disease controls [ODC] (n = 14) and in cerebral surgical resections for epilepsy [SURG] (n = 6). Deep sequencing of cerebral white matter-derived RNA from the HIV (n = 4) and ODC (n = 4) patients and SURG (n = 2) groups revealed bacterially-encoded 16 s RNA sequences in all brain specimens with α-proteobacteria representing over 70% of bacterial sequences while the other 30% of bacterial classes varied widely. Bacterial rRNA was detected in white matter glial cells by in situ hybridization and peptidoglycan immunoreactivity was also localized principally in glia in human brains. Analyses of amplified bacterial 16 s rRNA sequences disclosed that Proteobacteria was the principal bacterial phylum in all human brain samples with similar bacterial rRNA quantities in HIV and ODC groups despite increased host neuroimmune responses in the HIV group. Exogenous viruses including bacteriophage and human herpes viruses-4, -5 and -6 were detected variably in autopsied brains from both clinical groups. Brains from SIV- and SHIV-infected macaques displayed a profile of bacterial phyla also dominated by Proteobacteria but bacterial sequences were not detected in experimentally FIV-infected cat or RAG1⁻/⁻ mouse brains. Intracerebral implantation of human brain homogenates into RAG1⁻/⁻ mice revealed a preponderance of α-proteobacteria 16 s RNA sequences in the brains of recipient mice at 7 weeks post-implantation, which was abrogated by prior heat-treatment of the brain homogenate. Thus, α-proteobacteria represented the major bacterial component of the primate brain's microbiome regardless of underlying immune status, which could be transferred into naïve hosts leading to microbial persistence in the brain.


Assuntos
Síndrome da Imunodeficiência Adquirida , Alphaproteobacteria , Infecções Bacterianas do Sistema Nervoso Central , Cérebro , RNA Bacteriano , RNA Ribossômico , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/genética , Síndrome da Imunodeficiência Adquirida/metabolismo , Síndrome da Imunodeficiência Adquirida/patologia , Alphaproteobacteria/genética , Alphaproteobacteria/metabolismo , Animais , Autopsia , Gatos , Infecções Bacterianas do Sistema Nervoso Central/etiologia , Infecções Bacterianas do Sistema Nervoso Central/genética , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/microbiologia , Infecções Bacterianas do Sistema Nervoso Central/patologia , Cérebro/metabolismo , Cérebro/microbiologia , Cérebro/patologia , Síndrome de Imunodeficiência Adquirida Felina/genética , Síndrome de Imunodeficiência Adquirida Felina/metabolismo , Síndrome de Imunodeficiência Adquirida Felina/microbiologia , Síndrome de Imunodeficiência Adquirida Felina/patologia , Feminino , Humanos , Masculino , Camundongos , Camundongos Knockout , Neuroglia/metabolismo , Neuroglia/microbiologia , Neuroglia/patologia , RNA Bacteriano/genética , RNA Bacteriano/metabolismo , RNA Ribossômico/genética , RNA Ribossômico/metabolismo
5.
J Neurol Surg A Cent Eur Neurosurg ; 73(3): 147-52, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22190143

RESUMO

BACKGROUND AND AIM: To evaluate whether there is a cutoff value for a metabolite concentration measured by 1 H MR spectroscopy (MRS), which can be used to differentiate malignant brain tumors (high-grade gliomas, primary CNS lymphomas [PCNSL] and metastases) from other contrast-enhancing lesions like low-grade gliomas and non-neoplastic lesions. MATERIAL AND METHODS: 1 H MRS was performed in 252 consecutive patients with space-occupying brain lesions which were enhanced with application of a contrast agent. Concentrations of N-acetyl-aspartate, total creatine, choline containing metabolites (total choline, tCho), lipids, and lactate were evaluated from the contrast-enhancing part of the lesions and from the normal appearing brain tissue. Linear discriminant analysis was used to find the best predictor for malignant brain tumors. In addition, receiver operating characteristic analysis (ROC) was performed to determine a cutoff value for the best predictor in detecting malignant brain tumors with a specificity of >95%. RESULTS: All brain tumors and 20 out of 47 nonneoplastic lesions were examined histopathologically. The remaining 27 diagnoses were based on MR imaging, clinical findings, and follow-up. The final diagnosis was 134 high-grade gliomas (WHO grade III/IV), 36 metastases, 9 PCNSL, 8 low-grade gliomas (WHO grade I/II), 34 infections, 9 infarctions, 2 hematomas, and 2 vasculitides. 18 patients were excluded due to insufficient spectral quality. The tCho concentration was the best predictor to differentiate malignant brain tumors from enhancing low-grade gliomas or non-neoplastic lesions (F=26.6 [df: 25.833], p<0.0005). The ROC revealed that a cutoff tCho value, based on an increase of ≥40% compared to normal, yielded a specificity of 100% and a sensitivity of 89.4% to correctly diagnose a malignant brain tumor. CONCLUSION: 1 H MRS reliably differentiates malignant brain tumors from other contrast-enhancing brain lesions. At least a 40% increase of tCho compared to normal brain tissue indicates a malignant tumor (WHO grade III/IV gliomas, PCNSL, metastases) with >90% specificity and sensitivity.


Assuntos
Encefalopatias/diagnóstico , Neoplasias Encefálicas/diagnóstico , Colina/metabolismo , Glioma/diagnóstico , Linfoma/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Encefalopatias/patologia , Infarto Encefálico/diagnóstico , Infarto Encefálico/metabolismo , Neoplasias Encefálicas/patologia , Infecções Bacterianas do Sistema Nervoso Central/diagnóstico , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Hemorragia Cerebral/diagnóstico , Hemorragia Cerebral/metabolismo , Colina/análise , Meios de Contraste , Diagnóstico Diferencial , Análise Discriminante , Feminino , Glioma/patologia , Humanos , Linfoma/patologia , Imageamento por Ressonância Magnética , Espectroscopia de Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica/diagnóstico , Valor Preditivo dos Testes , Curva ROC , Vasculite/diagnóstico , Vasculite/metabolismo , Adulto Jovem
7.
Handb Clin Neurol ; 96: 17-29, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20109672

RESUMO

We have discussed important factors involved in choosing appropriate antimicrobial regimens for the treatment of bacterial meningitis and brain abscess to illustrate common themes relevant to the treatment of these diseases. We have limited this review to these conditions for two main reasons: (1) the principles involved in optimal antimicrobial therapy for these diseases likely apply to others CNS infections, such as viral and fungal diseases; and (2) little pharmacological information is currently available for other types of CNS infections. Many of the studies addressing the relevant pharmacological and microbiological aspects of antimicrobial therapy for CNS infections have been performed in experimental animal models and, as a result, the information derived from these studies may be different when examined in appropriate human studies. Our current understanding of appropriate antimicrobial therapy for CNS infections may be summarized as follows: 1. Choose bactericidal antimicrobials that effectively cross the BBB to achieve CSF concentrations well above the MBC (≥ 10-fold) for the suspected bacterial pathogen(s). 2. Take into consideration the relevant PD parameters the bactericidal activity of the antimicrobials used to treat bacterial meningitis, such as t > MBC or AUC/MBC. 3. Tailor the antimicrobial regimen based on microbiological information, once available. However, with respect to brain abscess therapy, keep in mind that anaerobes are commonly involved, but difficult to culture, and consider including antianaerobic therapy even if the bacterial cultures do not grow anaerobes. 4. Treat bacterial meningitis caused by nonmeningococcal pathogens for 7-10 days, but monitor clinical progress to determine whether the patient should continue on a more prolonged antimicrobial course. Meningococcal meningitis may be treated with 3-4 days of effective antimicrobial therapy, again with the caveat that the patients clinical course should dictate duration of therapy. 5. Treat brain abscess, preferably after aspiration/drainage, for at least 6 weeks with intravenous antimicrobials for brain abscess on the clinical response (e.g., improved symptoms, lack of new neurological findings) and radiographic changes (e.g., reduction in cavity size).


Assuntos
Anti-Infecciosos/uso terapêutico , Infecções Bacterianas do Sistema Nervoso Central/tratamento farmacológico , Corticosteroides/metabolismo , Animais , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Humanos
8.
Radiologe ; 48(6): 582-7, 2008 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-18504536

RESUMO

Magnetic resonance spectroscopy (MRS) is a non-invasive method for investigation of cerebral metabolite concentrations in various pathologic conditions. The clinical use of MRS for intracranial disorders is well established. In this review the characteristic MRS findings for the most important inflammatory brain diseases will be discussed.


Assuntos
Encéfalo/metabolismo , Encéfalo/patologia , Infecções Bacterianas do Sistema Nervoso Central/diagnóstico , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Encefalite Viral/diagnóstico , Encefalite Viral/metabolismo , Imageamento por Ressonância Magnética/métodos , Espectroscopia de Ressonância Magnética/métodos , Humanos , Proteínas do Tecido Nervoso/análise
9.
Cell Biol Int ; 32(7): 801-6, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18462959

RESUMO

Abnormal fluid accumulation in tissues, including the life-threatening cerebral and pulmonary edema, is a severe consequence of bacteria infection. Chlamydia (C.) trachomatis is an obligate intracellular gram-negative human pathogen responsible for a spectrum of diseases, causing tissue fluid accumulation and edema in various organs. However, the underlying mechanism for tissue fluid secretion induced by C. trachomatis and most of other infectious pathogens is not known. Here, we report that in mice C. trachomatis infection models, the expression of cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP activated chloride channel, is up regulated together with increased cytokine release and tissue fluid accumulation that can be reversed by treatment with antibiotic specific for C. trachomatis and CFTR channel blocker. However, C. trachomatis infection cannot induce tissue edema in CFTRtm1Unc mutant mice. Administration of exogenous IL-1beta to mice mimics the C. trachomatis infection-induced CFTR upregulation, enhanced CFTR channel activity and fluid accumulation, further confirming the involvement of CFTR in infection-induced tissue fluid secretion.


Assuntos
Infecções por Chlamydia/metabolismo , Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Edema/metabolismo , Interleucina-1beta/metabolismo , Animais , Encefalopatias/metabolismo , Edema Encefálico/etiologia , Edema Encefálico/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Infecções por Chlamydia/microbiologia , Chlamydia trachomatis/metabolismo , Fibrose Cística/metabolismo , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Citocinas/metabolismo , Modelos Animais de Doenças , Edema/etiologia , Feminino , Interleucina-1beta/farmacologia , Camundongos , Camundongos Endogâmicos CFTR , Regulação para Cima , Doenças Uterinas/metabolismo
10.
J Neurochem ; 99(2): 596-607, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16879708

RESUMO

In contrast to the role of lipopolysaccharide from Gram-negative bacteria, the role of Gram-positive bacterial components in inducing inflammation in the CNS remains controversial. We studied the potency of highly purified lipoteichoic acid and muramyl dipeptide isolated from Staphylococcus aureus to activate primary cultures of rat microglia. Exposure of pure microglial cultures to lipoteichoic acid triggered a significant time- and dose-dependent production of pro-inflammatory cytokines (tumour-necrosis factor-alpha, interleukin-1beta, interleukin-6) and nitric oxide. Muramyl dipeptide strongly and selectively potentiated lipoteichoic acid-induced inducible nitric oxide synthase expression and nitric oxide production. However, it did not have any significant influence on the production of pro-inflammatory cytokines. As bacterial components are recognised by the innate immunity through Toll-like receptors (TLRs) we showed that lipoteichoic acid was recognised in microglia by the TLR2 and lipopolysaccharide by the TLR4, as cells isolated from mice lacking TLR2 or TLR4 did not produce pro-inflammatory cytokines and nitric oxide upon lipoteichoic acid or lipopolysaccharide stimulation, respectively. Lipoteichoic acid-induced glia activation was mediated by p38 and ERK1/2 MAP kinases, as pretreatment with inhibitor of p38 or ERK1/2 decreased lipoteichoic acid-induced cytokine release, iNOS mRNA expression and nitric oxide production. The observed pro-inflammatory response induced by lipoteichoic acid-activated microglia could play a major role in the inflammatory response of CNS induced by Gram-positive bacteria.


Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Infecções Bacterianas do Sistema Nervoso Central/imunologia , Lipopolissacarídeos/farmacologia , Microglia/imunologia , Óxido Nítrico/metabolismo , Ácidos Teicoicos/farmacologia , Receptor 2 Toll-Like/metabolismo , Acetilmuramil-Alanil-Isoglutamina/imunologia , Acetilmuramil-Alanil-Isoglutamina/metabolismo , Animais , Animais Recém-Nascidos , Células Cultivadas , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Citocinas/imunologia , Citocinas/metabolismo , Relação Dose-Resposta a Droga , Encefalite/imunologia , Encefalite/metabolismo , Encefalite/fisiopatologia , Inibidores Enzimáticos/farmacologia , MAP Quinases Reguladas por Sinal Extracelular/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Mediadores da Inflamação/imunologia , Mediadores da Inflamação/metabolismo , Mediadores da Inflamação/farmacologia , Lipopolissacarídeos/imunologia , Microglia/efeitos dos fármacos , Microglia/metabolismo , Óxido Nítrico Sintase Tipo II/efeitos dos fármacos , Óxido Nítrico Sintase Tipo II/genética , Óxido Nítrico Sintase Tipo II/imunologia , Ratos , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Ácidos Teicoicos/imunologia , Fatores de Tempo , Receptor 2 Toll-Like/efeitos dos fármacos , Receptor 4 Toll-Like/efeitos dos fármacos , Receptor 4 Toll-Like/imunologia , Receptor 4 Toll-Like/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
11.
CNS Neurol Disord Drug Targets ; 5(4): 381-9, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16918390

RESUMO

Numerous reports indicate that lipid or protein associated carbohydrates are essential for infection of cells by various viruses, bacteria, or bacterial toxins, some of which affect the nervous system. Examples of such pathogens include tetanus and botulinum neurotoxin, Shiga and Shiga-like toxins, Borrelia burgdorferi, Mycobacterium leprae, and human immunodeficiency virus. This review discusses evidence indicating that carbohydrates are essential for these pathogens to induce their deleterious effects, the putative function of the carbohydrates, and how this knowledge might be used to combat the effects of the pathogen.


Assuntos
Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Viroses do Sistema Nervoso Central/metabolismo , Glicoconjugados/metabolismo , Glicolipídeos/metabolismo , Complexo AIDS Demência/metabolismo , Complexo AIDS Demência/fisiopatologia , Animais , Toxinas Bacterianas/metabolismo , Moléculas de Adesão Celular/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/fisiopatologia , Viroses do Sistema Nervoso Central/fisiopatologia , Humanos , Lectinas Tipo C/metabolismo , Receptores de Superfície Celular/efeitos dos fármacos , Receptores de Superfície Celular/metabolismo , Proteínas Virais de Fusão/metabolismo
12.
Glia ; 53(3): 322-30, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16265673

RESUMO

There is growing appreciation that resident brain cells can initiate and/or regulate inflammation after trauma or infection in the central nervous system (CNS). Recent studies from our laboratory have begun to shed light on the mechanisms by which astrocytes perceive bacterial challenges by demonstrating the functional expression of Toll-like receptors (TLR) in this cell type. In the present study, we demonstrate that astrocytes also express members of the novel nucleotide-binding oligomerization domain (NOD) family of proteins that can serve as cytosolic pattern recognition receptors. We show that isolated cultures of murine astrocytes constitutively express robust levels of NOD2, a molecule that can recognize a minimal peptidoglycan motif. Expression of NOD2 is significantly upregulated after exposure to two disparate and clinically relevant bacterial pathogens of the CNS, Borrelia burgdorferi and Neisseria meningitidis. Similarly, NOD2 protein expression is elevated after exposure to specific bacterial ligands for TLRs. Importantly, we show that astrocytes express Rip2 kinase, an essential downstream effector molecule for NOD-mediated cell responses, and demonstrate that this expression is upregulated after bacterial challenge. Furthermore, we confirm the functional nature of NOD2 in astrocytes by demonstrating that a specific ligand for this receptor induces significant inflammatory cytokine production and augments immune responses induced by TLR ligation. Taken together, the present demonstration that astrocytes express functional NOD2 proteins may represent a potentially important mechanism by which this glial cell type initiates either protective host responses within the brain or the progression of damaging CNS inflammation.


Assuntos
Astrócitos/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Animais , Animais Recém-Nascidos , Antígenos de Bactérias/isolamento & purificação , Antígenos de Bactérias/farmacologia , Western Blotting , Borrelia burgdorferi , Separação Celular , Citocinas/biossíntese , Citosol/metabolismo , Densitometria , Lipopolissacarídeos/farmacologia , Doença de Lyme/metabolismo , Meningite Meningocócica/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Neisseria meningitidis , Proteína Adaptadora de Sinalização NOD2 , Proteínas Serina-Treonina Quinases/metabolismo , RNA/biossíntese , Proteína Serina-Treonina Quinase 2 de Interação com Receptor , Proteína Serina-Treonina Quinases de Interação com Receptores , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Receptores Toll-Like/biossíntese , Peptídeos e Proteínas Associados a Receptores de Fatores de Necrose Tumoral/metabolismo , Regulação para Cima/fisiologia
13.
Acta Paediatr ; 93(9): 1178-84, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15384880

RESUMO

AIM: To evaluate the expression of neurotrophic factors (nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF)) and their association with the clinical-radiological characteristics and outcome of children with viral and bacterial meningoencephalitis (ME). METHODS: Prospective observational clinical study performed on 13 children with ME and 12 controls with non-inflammatory obstructive hydrocephalus. Neurotrophic factor levels in the cerebro-spinal fluid (CSF) and plasma were measured using an immunoenzymatic assay. RESULTS: High levels of NGF and BDNF were demonstrated in all patients, while GDNF levels did not undergo significant variations. NGF expression in the CSF was higher in viral ME than in bacterial ME and was correlated with CSF cellularity (particularly mononuclear cells). BDNF expression in the CSF was higher in bacterial ME than in viral ME and was correlated with CSF cellularity and blood platelet count. No relationships were noted between CSF protein or serum C-reactive protein levels and the expression of neurotrophic factors. Regarding clinical and radiological features, elevated NGF/BDNF levels in the CSF correlated with higher incidence of seizures and prolonged comatose state and with specific radiological lesions. No correlation was found between NGF/BDNF levels and final outcome. CONCLUSIONS: The variations in neurotrophic factor levels may reflect an endogenous attempt at neuroprotection against biochemical and molecular changes during both viral and bacterial ME. The expression of these factors is likely to play a neuro-immunomodulatory or neurosurvival role in ME infections.


Assuntos
Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Viroses do Sistema Nervoso Central/metabolismo , Meningoencefalite/metabolismo , Fatores de Crescimento Neural/sangue , Fatores de Crescimento Neural/líquido cefalorraquidiano , Estudos de Casos e Controles , Infecções Bacterianas do Sistema Nervoso Central/diagnóstico por imagem , Viroses do Sistema Nervoso Central/diagnóstico por imagem , Criança , Pré-Escolar , Feminino , Escala de Resultado de Glasgow , Humanos , Lactente , Masculino , Meningoencefalite/microbiologia , Meningoencefalite/virologia , Estudos Prospectivos , Radiografia
14.
Curr Opin Neurol ; 16(3): 267-73, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12858061

RESUMO

PURPOSE OF REVIEW: Axonal dysfunction and damage is an early pathological sign of autoimmune central nervous system disease, viral and bacterial infections, and brain trauma. Axonal injury has attracted considerable interest during the past few years because the degree of axonal damage appears to determine long-term clinical outcome. RECENT FINDINGS: Advanced magnetic resonance spectroscopic imaging techniques have suggested that axonal loss and dysfunction is responsible for the persistent neurological deficits that occur in patients with multiple sclerosis. Histopathological methods have shown that axonal damage is defined primarily by dysfunction of axonal transport, and finally by complete transection and degeneration of axons. Recent studies have demonstrated that the extent of axonal damage in the primary demyelinating lesion of multiple sclerosis patients is associated with the number of activated microglia/macrophages and cytotoxic CD8+ T lymphocytes. In addition, diffuse axonal dysfunction independent of demyelination develops in normal appearing white matter, possibly due to indirect effects of inflammation. SUMMARY: The fact that axonal damage in response to overt inflammatory reactions may occur gradually, leaving a window for therapeutical intervention, has important clinical implications. Determination of the exact molecular mechanism might help in finding new therapies for inflammatory axonal damage.


Assuntos
Axônios/metabolismo , Axônios/patologia , Doenças do Sistema Nervoso Central/metabolismo , Doenças do Sistema Nervoso Central/patologia , Degeneração Neural/metabolismo , Animais , Doenças Autoimunes do Sistema Nervoso/metabolismo , Doenças Autoimunes do Sistema Nervoso/patologia , Transporte Axonal , Linfócitos T CD8-Positivos/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/patologia , Viroses do Sistema Nervoso Central/metabolismo , Viroses do Sistema Nervoso Central/patologia , Humanos , Inflamação/metabolismo , Inflamação/patologia , Macrófagos/metabolismo , Espectroscopia de Ressonância Magnética , Microglia/metabolismo , Esclerose Múltipla/metabolismo , Esclerose Múltipla/patologia
15.
J Neurol Neurosurg Psychiatry ; 74(6): 788-9, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12754353

RESUMO

Activated microglia, the resident macrophages of the brain, are a feature of Alzheimer's disease. Animal models suggest that when activated microglia are further activated by a subsequent systemic infection this results in significantly raised levels of interleukin 1beta within the CNS, which may in turn potentiate neurodegeneration. This prospective pilot study in Alzheimer's disease subjects showed that cognitive function can be impaired for at least two months after the resolution of a systemic infection and that cognitive impairment is preceded by raised serum levels of interleukin 1beta. These relations were not confounded by the presence of any subsequent systemic infection or by baseline cognitive scores. Further research is needed to determine whether recurrent systemic infections drive cognitive decline in Alzheimer's disease subjects through a cytokine mediated pathway.


Assuntos
Doença de Alzheimer/etiologia , Doença de Alzheimer/metabolismo , Infecções Bacterianas do Sistema Nervoso Central/complicações , Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/etiologia , Interleucina-1/metabolismo , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Interleucina-1/sangue , Masculino , Testes Neuropsicológicos
16.
Hunan Yi Ke Da Xue Xue Bao ; 23(5): 429-31, 1998.
Artigo em Chinês | MEDLINE | ID: mdl-10682551

RESUMO

Concentrations of amino acids such as glutamate(Glu), glutamine(Gln), gamma-aminobutyric (GABA), glycerin(Gly) in rat cerebral cortex were measured by o-phthaldialdehyde method to clarify alterations of these amino acids in infectious brain injuries(IBI). The results were that Gln and GABA in groups treated by bordetella pertussis suspension(BP) 4h were increased compared to those in the group treated by the normal saline(NS) or the operative control(OC) and a positive correlation with water content or Evans blue content, respectively. In the 24h BP group, Gln was still increased; GABA and Gly were decreased compared to those in the NS or OC group. The findings suggest that GLu, Gln, and Gly play an important role and GABA may be a marker of injury in pathogenetic mechanism of IBI induced by BP.


Assuntos
Infecções Bacterianas do Sistema Nervoso Central/metabolismo , Córtex Cerebral/metabolismo , Ácido Glutâmico/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Bordetella pertussis , Glutamina/metabolismo , Glicerol/metabolismo , Masculino , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Coqueluche
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA